KAIRAX Aftercare leaflets x20
Kairax
Clinic supplies & patient materialsDermal filler aftercare leaflets
Certifications
- Printed aftercare leaflets are not medical devices and therefore do not carry CE marking or MHRA authorisation themselves.
- Leaflets reference Kairax hyaluronic acid dermal filler, which is described by the brand as a fully CE Approved product containing lidocaine.
- Printed aftercare leaflets are not medical devices and therefore do not carry CE marking or MHRA authorisation themselves.
- Leaflets reference Kairax hyaluronic acid dermal filler, which is described by the brand as a fully CE Approved product containing lidocaine.
Dermal filler aftercare leaflets
Description
KAIRAX Aftercare leaflets x20 are branded patient-information leaflets designed to support clinics using Kairax hyaluronic acid dermal fillers. Each leaflet provides post-treatment guidance specific to Kairax filler procedures, including how to care for the treated area, what sensations to expect during the healing period, and tips to optimise treatment results. The pack contains 20 printed leaflets, allowing practitioners to give clear, consistent aftercare instructions to every Kairax patient.
Bnefits
- Provides clear, branded aftercare guidance tailored to Kairax dermal filler treatments
- Helps standardise post-procedure instructions across practitioners within a clinic
- Improves patient understanding of normal post-treatment sensations and expected healing timeline
- Supports better treatment outcomes and patient satisfaction by reinforcing correct aftercare behaviour
- Time-saving resource for practitioners who can supplement verbal advice with written instructions
- Professional Kairax branding reinforces clinic presentation and product identity
Indications
- To be given to patients immediately after a Kairax hyaluronic acid dermal filler treatment
- For use by aesthetic clinics and medical professionals who administer Kairax fillers (Deep, Fine, Sub Q or other Kairax variants)
- To provide written guidance on aftercare, expected post-treatment effects and when to contact the clinic
Composition
- Printed paper leaflet with Kairax branding and written aftercare instructions for Kairax dermal filler treatments
- Standard commercial printing inks and paper (exact paper weight and finish not specified in supplier information)
Formulation
- Pack format: 20 individual Kairax aftercare leaflets per pack
- Leaflet content: Kairax-specific dermal filler aftercare guidance (care of treated area, expected sensations, optimisation tips)
- Exact leaflet size, page count and layout are not specified in publicly available listings
Packaging
- Supplied as a single retail pack containing 20 Kairax aftercare leaflets
- Leaflets are bundled/packed together for clinic use (exact wrapping or banding method not specified)
- Pack labelled online as "KAIRAX Aftercare leaflets x20" with price and stock status
Usage
- Intended for use by clinics and qualified practitioners who perform Kairax dermal filler treatments.
- After completing a Kairax procedure, provide one leaflet to each patient and go through the key points verbally.
- Advise patients to keep the leaflet and refer to it during the first days after treatment for guidance on normal post-treatment sensations and care instructions.
- Typical aftercare guidance (as commonly provided for HA dermal fillers) may include: avoiding touching or massaging the treated area unless instructed, avoiding make-up for several hours, avoiding extreme heat or cold, limiting alcohol and strenuous exercise for 24 hours, and using sunscreen.
- Use the leaflet alongside clinic-specific consent forms and medical advice; it is not a substitute for professional clinical judgement.
- Dispose of damaged or outdated leaflets and replace with current versions to ensure that information remains accurate and aligned with the latest Kairax guidance.
Contraindications
- No direct medical contraindications apply to the leaflet itself.
- Patients with visual or reading difficulties may require additional verbal or alternative-format instructions.
- Clinical contraindications relate to Kairax dermal filler treatment and must be assessed separately by the treating practitioner.
Adverse Effects
- No direct medical adverse effects are associated with the leaflet itself.
- Risk of misunderstanding or non-compliance if the leaflet is not explained or if patients do not read it; practitioners should review key points verbally to minimise this risk.
Storage Conditions
- Store leaflets in a cool, dry place away from direct sunlight to prevent fading or paper damage.
- Keep flat or upright in a document holder to avoid creasing or tearing.
- Avoid exposure to moisture, oils or treatment-room chemicals which could stain or damage the paper.
- Monitor stock and replace with updated versions if the manufacturer or distributor releases revised aftercare information.
Duration
Not applicable; this is an informational aftercare product used to support the post-treatment period following Kairax dermal filler procedures.
Onset
Not applicable; the leaflet itself has no clinical effect but supports appropriate aftercare immediately after treatment and during the healing period.
